324 related articles for article (PubMed ID: 37397865)
1. Cardiac amyloidosis: state-of-the-art review.
Bukhari S
J Geriatr Cardiol; 2023 May; 20(5):361-375. PubMed ID: 37397865
[TBL] [Abstract][Full Text] [Related]
2. EXPRESS: Epidemiology, Diagnosis and Management of Cardiac Amyloidosis.
Bashir Z; Younus A; Dhillon S; Kasi A; Bukhari S
J Investig Med; 2024 Jun; ():10815589241261279. PubMed ID: 38869161
[TBL] [Abstract][Full Text] [Related]
3. The importance of pathways to facilitate early diagnosis and treatment of patients with cardiac amyloidosis.
Kwok CS; Moody WE
Ther Adv Cardiovasc Dis; 2023; 17():17539447231216318. PubMed ID: 38099406
[TBL] [Abstract][Full Text] [Related]
4. Transthyretin cardiac amyloidosis.
Porcari A; Fontana M; Gillmore JD
Cardiovasc Res; 2023 Feb; 118(18):3517-3535. PubMed ID: 35929637
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and predictors of atrial fibrillation in patients with light-chain or transthyretin cardiac amyloidosis.
Papathanasiou M; Jakstaite AM; Oubari S; Siebermair J; Wakili R; Hoffmann J; Carpinteiro A; Hagenacker T; Thimm A; Rischpler C; Kessler L; Rassaf T; Luedike P
ESC Heart Fail; 2022 Jun; 9(3):1740-1748. PubMed ID: 35178887
[TBL] [Abstract][Full Text] [Related]
6. Prevalence, Incidence, and Impact on Mortality of Conduction System Disease in Transthyretin Cardiac Amyloidosis.
Donnellan E; Wazni OM; Saliba WI; Hanna M; Kanj M; Patel DR; Wilner B; Kochar A; Jaber WA
Am J Cardiol; 2020 Aug; 128():140-146. PubMed ID: 32650908
[TBL] [Abstract][Full Text] [Related]
7. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
Rubin J; Maurer MS
Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
[TBL] [Abstract][Full Text] [Related]
8. Amyloid cardiomyopathy.
Kristen AV
Herz; 2020 May; 45(3):267-271. PubMed ID: 32107564
[TBL] [Abstract][Full Text] [Related]
9. Cardiac Amyloidosis Treatment.
Stern LK; Patel J
Methodist Debakey Cardiovasc J; 2022; 18(2):59-72. PubMed ID: 35414852
[TBL] [Abstract][Full Text] [Related]
10. Narrative review of pharmacotherapy for transthyretin cardiac amyloid.
Cruz Rodriguez JB; Tallaj JA
Ann Transl Med; 2021 Mar; 9(6):519. PubMed ID: 33850916
[TBL] [Abstract][Full Text] [Related]
11. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments.
Sekijima Y
J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):1036-43. PubMed ID: 25604431
[TBL] [Abstract][Full Text] [Related]
12. Treatment of amyloidosis: present and future.
Mallus MT; Rizzello V
Eur Heart J Suppl; 2023 Apr; 25(Suppl B):B99-B103. PubMed ID: 37091663
[TBL] [Abstract][Full Text] [Related]
13. Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review.
Ruberg FL; Grogan M; Hanna M; Kelly JW; Maurer MS
J Am Coll Cardiol; 2019 Jun; 73(22):2872-2891. PubMed ID: 31171094
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in the diagnosis and management of amyloid cardiomyopathy.
Nijst P; Tang WW
Fac Rev; 2021; 10():31. PubMed ID: 33817700
[TBL] [Abstract][Full Text] [Related]
15. Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage.
Law S; Petrie A; Chacko L; Cohen OC; Ravichandran S; Gilbertson JA; Rowczenio D; Wechalekar A; Martinez-Naharro A; Lachmann HJ; Whelan CJ; Hutt DF; Hawkins PN; Fontana M; Gillmore JD
ESC Heart Fail; 2020 Dec; 7(6):3942-3949. PubMed ID: 32924285
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular Involvement in Transthyretin Cardiac Amyloidosis.
Lioncino M; Monda E; Palmiero G; Caiazza M; Vetrano E; Rubino M; Esposito A; Salerno G; Dongiglio F; D'Onofrio B; Verrillo F; Cerciello G; Manganelli F; Pacileo G; Bossone E; Golino P; Calabrò P; Limongelli G
Heart Fail Clin; 2022 Jan; 18(1):73-87. PubMed ID: 34776085
[TBL] [Abstract][Full Text] [Related]
17. Imaging of cardiac amyloidosis by (99m)Tc-PYP scintigraphy.
Papantoniou V; Valsamaki P; Kastritis S; Tsiouris S; Delichas Z; Papantoniou Y; Tsiouma M; Athanasoulis T; Fotopoulos A; Dimopoulos MA
Hell J Nucl Med; 2015; 18 Suppl 1():42-50. PubMed ID: 26665211
[TBL] [Abstract][Full Text] [Related]
18. (99m)Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis.
Pilebro B; Suhr OB; Näslund U; Westermark P; Lindqvist P; Sundström T
Ups J Med Sci; 2016; 121(1):17-24. PubMed ID: 26849806
[TBL] [Abstract][Full Text] [Related]
19. Multimodal Imaging and Biomarkers in Cardiac Amyloidosis.
Jung MH; Chang S; Han EJ; Youn JC
Diagnostics (Basel); 2022 Mar; 12(3):. PubMed ID: 35328180
[TBL] [Abstract][Full Text] [Related]
20. Native T1 mapping in transthyretin amyloidosis.
Fontana M; Banypersad SM; Treibel TA; Maestrini V; Sado DM; White SK; Pica S; Castelletti S; Piechnik SK; Robson MD; Gilbertson JA; Rowczenio D; Hutt DF; Lachmann HJ; Wechalekar AD; Whelan CJ; Gillmore JD; Hawkins PN; Moon JC
JACC Cardiovasc Imaging; 2014 Feb; 7(2):157-65. PubMed ID: 24412190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
